Ramatroban

Overview

Ramatroban is a selective thromboxane A 2 ( TxA 2 , IC 50 =14 nM) antagonist, which also antagonizes CRTH2 ( IC 50 =113 nM) by inhibiting PGD 2 binding.

Application

Products | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Endocrinology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-B0745
• CAS No.: 116649-85-5
• Molecular Formula: C21H21FN2O4S
• Molecular Weight: 416.47
• Purity: 99.23%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (4.99 mM); Clear solution
• Availability: In-stock

Source

Original product source